Novonesis (Novozymes) B (MEX:NSISN) Construction In Progress: MXN0 Mil (As of Mar. 2026)


MEX:NSISN Novonesis (Novozymes) B MEX:NSISN
91 GF Score
Price MXN911.11
GF Value MXN979.45
! 3 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B Construction In Progress?

Novonesis (Novozymes) B MEX:NSISN 91 Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:NSISN with a GF Score™ of 91/100 and a GF Value™ of MXN979.45. The stock has 3 warning signs investors should review.

Novonesis (Novozymes) B's quarterly construction in progress increased from Sep. 2025 (MXN0 Mil) to Dec. 2025 (MXN15,265 Mil) but then declined from Dec. 2025 (MXN15,265 Mil) to Mar. 2026 (MXN0 Mil).

Novonesis (Novozymes) B's annual construction in progress increased from Dec. 2023 (MXN4,387 Mil) to Dec. 2024 (MXN13,535 Mil) and increased from Dec. 2024 (MXN13,535 Mil) to Dec. 2025 (MXN15,265 Mil).

Novonesis (Novozymes) B Construction In Progress Historical Data

* Premium members only.

The historical data trend for Novonesis (Novozymes) B's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B Construction In Progress Chart

Novonesis (Novozymes) B Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,730.22 8,027.17 4,387.02 13,535.46 15,264.79

Novonesis (Novozymes) B Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 15,264.79 0.00
MEX:NSISN
91GF Score
Novonesis (Novozymes) B MEX:NSISN
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novonesis (Novozymes) B Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN0 Mil mean?
Novonesis (Novozymes) B (MEX:NSISN) has a Construction In Progress of MXN0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Novonesis (Novozymes) B and its competitors.
Is Novonesis (Novozymes) B's Construction In Progress too high?
Novonesis (Novozymes) B's current Construction In Progress is MXN0 Mil. Overall, Novonesis (Novozymes) B has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Construction In Progress compare to LIN and SHW?
Novonesis (Novozymes) B's Construction In Progress of MXN0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Chemicals company?
A good Construction In Progress depends on the Chemicals industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Novonesis (Novozymes) B and its competitors. Novonesis (Novozymes) B's current Construction In Progress is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Novonesis (Novozymes) B (MEX:NSISN) has a current Construction In Progress of MXN0 Mil. The stock's GF Value™ is MXN979.45, compared to a current price of MXN911.11 — trading 7% below its estimated fair value. The current Construction In Progress is MXN0 Mil. Novonesis (Novozymes) B's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Novonesis (Novozymes) B (MEX:NSISN), the current Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (MEX:NSISN) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued. The current stock price of MXN911.11 is trading 7% below its estimated GF Value™ of MXN979.45.

Key valuation signals for MEX:NSISN:

  • Construction In Progress: MXN0 Mil
  • GF Value™: MXN979.45 vs. price of MXN911.11 (7% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the MEX:NSISN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
91GF Score

Get the complete analysis for MEX:NSISN

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN911.11
Price
MXN979.45
GF Value